Also found in: Medical.
FAST-1Fork-Head Activin Signal Transducer-1
References in periodicals archive ?
In FAST-1, the primary endpoint in median time to onset of symptom relief was 2.
A total of 11 laryngeal attacks were treated in the FAST-1 and FAST-2 trial controlled phase, with patients reporting a median time of 1 hour (FAST-2) and 0.
Further response of Icatibant efficacy was demonstrated in the combined analysis of FAST-1 and FAST-2, with data meeting both the primary endpoint and all secondary endpoints entered into the analysis.